BSCL2 and lipodystrophy: Although we speculated that the lack of lipodystrophy in that model may have protected against metabolic dysfunction, our data now provide strong additional evidence that Bscl2 is unlikely to play a cell-autonomous role in the liver, even in the presence of lipodystrophy.